Archives

On June 4th, thousands of individuals from across the globe will head to Boston – but not for a Red

Eli Lilly is making a splash in the fast-moving, highly competitive field of cancer immunotherapy. With a $1.6 billion cash

After having spent seven years on technology incubation in India and more than a decade of Biotechnology research abroad, Epygen

Getting a new drugmaking technology through clinical development and to market is a major milestone, the culmination of years of

For decades now, climate change activists have used the scientific evidence of global warming to justify their efforts to increase

The iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) — which is an exchange-traded fund that holds nearly 200 biotech stocks —

Medical Engineering Innovations, a Madison, WI-based developer of medical devices that use radio frequency energy to zap tumors, is raising

[Source: Research & Innovation] By developing gender-inclusive guidelines and criteria for schools, museums, science centres and industry, an EU-funded project

Anish Suri has been appointed chief scientific officer of preclinical-stage immunotherapy developer Cue Biopharma (NASDAQ: CUE). Suri most recently worked

Last year, the winners of the inaugural Xconomy Awards included a 30-year-old CEO of a young cell therapy startup commercializing